Charles Schwab Investment Management Inc. Grows Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Charles Schwab Investment Management Inc. lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 0.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,153,450 shares of the real estate investment trust’s stock after purchasing an additional 53,392 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.45% of Healthpeak Properties worth $205,810,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of DOC. JPMorgan Chase & Co. boosted its stake in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $1,880,000. Swedbank AB purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $1,832,000. Pathstone Holdings LLC bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at $1,968,000. Finally, Associated Banc Corp purchased a new position in Healthpeak Properties in the 3rd quarter worth $10,559,000. 93.57% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Wells Fargo & Company cut their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Wedbush dropped their target price on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. Robert W. Baird dropped their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Finally, Mizuho cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Trading Down 1.5 %

NYSE:DOC opened at $20.11 on Friday. The company has a 50-day moving average price of $20.19 and a 200-day moving average price of $21.31. The stock has a market cap of $14.07 billion, a price-to-earnings ratio of 57.45, a P/E/G ratio of 2.17 and a beta of 1.15. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12 month low of $16.66 and a 12 month high of $23.26.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date was Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.07%. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.